Photobiomodulation Equipment and Training - THOR Photomedicine

Select Region

Information contained on this page may not be appropriate for your region, please select your region from below. To navigate back to this region selector, please click "Region" in the footer.
Do More With A THOR
Lots of happy THOR customer testimonials
NovoTHOR Whole Body Light Pod

THOR Photobiomodulation Therapy for Wound Healing


I am a tissue viability clinical nurse specialist at Harrow Primary Care Trust. You kindly lent the District Nurses one of your units to try for one of their patients.

Being perfectly honest, we all were very sceptical about the product, but now we have to eat our words.

The girls have been using it for over two weeks now and so far it looks very promising. The patient's pain has improved dramatically. Prior to initiating the treatment she would not allow anyone to touch her legs even to clean them. Now she is actually helping with the the dressing changes. The district nurses are also planning to reduce the number of visits from daily to alternate days, as exudate levels decrease. The bed wound is now 100% granulating tissue.

The success of this individual patient's experience with this therapy has amazed everyone so much that there is talk of either purchasing or renting a unit.

I have been asked by my manager to write a business plan to put before the board to ask for monies to fund this.

Sylvia Leonard

Trauma and Related Services
Glasgow Royal Infirmary
Department of Orthopaedics
Glasgow Royal Infirmary Hospital

Dear James,

Thank you for agreeing to loan the laser unit to the department.

We have predominately been using the light intensity aspect of the unit for wound healing, in particular on one patient who has shown remarkable improvement over the short time we have used it.

Previously the wounds had become static through the healing process. All of these wounds had been static in nature with no significant improvement for at least one month.

Since initiating the light therapy treatments the wounds have decreased visually within one week and have continued to do so weekly.

Due to the significant nature and severity of the wounds, although they have not completely resolved yet, one wound has almost healed, with the other wounds progressing quickly.

In addition we have been using the 3B laser unit as a non surgical option for patients with morton's neuroma and digital neuritis.

Again patient's have reported significant improvements in their level of pain after a few sessions.

We are finding the use of the laser unit to be a very positive and easy experience from the view of operators and from patients.


Melanie Kay
Orthopaedic Podiatrist

Please share your experiences:
If laser therapy has helped you in any way, please send us an email and share your experiencces.

Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers

THOR Photomedicine Ltd is an ISO 13485:2016 certified medical device company.

The THOR LX2.3 Photobiomodulation system has a medical CE mark (EC certificate). It is indicated for oral mucositis, tendinopathies, joint pain, neck pain and back pain for marketing in the UK, EU and Australia.

The THOR LX2.3 Photobiomodulation system is also FDA Cleared for marketing in the United States for: Temporary increase in local blood circulation, temporary relief of minor muscle and joint aches, pains and stiffness and relaxation of muscles; for muscle spasms, and minor pain and stiffness associated with arthritis.

Excluding the THOR LED Helmet, THOR LX2 and NovoTHOR systems are manufactured under conditions fulfilling the quality system requirements of Annex II, excluding (4), of the directive 93/42/EEC as amended and satisfy the applicable international harmonised standards.

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Quality certificates